A prefilled syringe is a single-dose packet of vaccine to which the manufacturer has fixed a needle. Prefilled syringes essentially eliminate the processes that are required before using a drug in a vial. It helps eliminate dosing errors because prefilled syringes contain the exact dose of Prefilled Syringes. Prefilled syringes continue to be used, mostly in the field of specific drugs such as insulin and tumors. Prefilled syringes are now used across a wide array of therapeutics sectors outside of the traditional domains of anticoagulants and vaccines. Prefilled provide greater patient safety by reducing the potential for inadvertent needle sticks and exposure to toxic products that can occur while drawing medication from vials.
Global Prefilled Syringes Market likely to grow at a momentous rate during the forecast period, 2020-2027. The growing prevalence of chronic diseases and a large patient population base are projected to fuel the global prefilled syringes market in the upcoming periods. Moreover, the increasing demand for efficient and easy-to-use drug delivery devices, coupled with helping healthcare professionals to minimize human errors in drug delivery errors, will augment the global prefilled syringes market size. Additionally, the rise in home-based healthcare, the surge in adoption of drugs along with increment in chronic disease, is major factors estimated to foster the growth of the global prefilled syringes industry in the future timespan.
Further, the growing adoption of prefilled syringes for its benefits such as increased product life span and minimized drug wastage compared to conventional methods will contribute to the growth of the prefilled syringes market in the next few years. In addition, technological advancement in the biopharmaceutical industry has impacted to help minimize the loss of potency while transferring biopharmaceuticals in different containers are projected to boom the global prefilled syringes industry.
The usage of the prefilled syringe has risen as the prefilled syringes have advantages over traditional packaging in vials include ease of use, and it helps eliminate dosing errors because prefilled syringes actually contain the exact dose. Also, the surge in the adoption of self-care devices and the high demand for improved safety in injectables will boom the prefilled syringes market in the forecast period.
There are common chronic cardiovascular diseases, cancer, diabetes, chronic respiratory disease, cerebrovascular disease center include high blood pressure, stroke, and coronary heart disease. According to WHO, the projected number of deaths attributable to chronic diseases rising from 3.78 million in 1990 (40.4% of all deaths) to an expected 7.63 million in 2020 (66.7% of all deaths). Due to these expected numbers, there will be a huge demand for home-based prefilled syringes in the upcoming years.
The self-injection device designed for patients with chronic diseases that affect their flexibility, and it reduces the waste of medicine, and the dose is adjustable and automatically return to zero after the injection is completed. It comprises accurate dosage volumes and already reconstituted drugs, which help eliminate confusion regarding dosage volumes and wastage of drugs. Self-injection helps the patient for more flexibility in terms of place and time of treatment, thereby substantially reducing therapy costs and support patients from the prescription of their new self-injectable through their at-home treatment.
Based on material, the global Prefilled Syringes market bifurcated into Glass Prefilled Syringes, and Plastic Prefilled Syringes. The glass prefilled syringes segment accounted for a higher revenue share in 2019 owing to the high growing use of glass in manufacturing syringes as a result of its nonreactive nature and heat and chemical resistance. It is compatible with different filling machines and drugs.
The Plastic Prefilled Syringes segment projected to gain market share in the forecast timeline. It is due to it has breakage design and flexible compared to glass, and it shows minimal drug adsorption, and decreased surface reactivity.
Based on the design, the global Prefilled Syringes market categorized into Single-Chamber Prefilled Syringes, Dual Prefilled Syringes, and Customized Prefilled Syringes. The single-chamber prefilled syringes segment accounted for major revenue in 2019, and it is anticipated to witness robust growth over the forecast period. It is due to the growing adoption of self-administered parental drugs and the rising prevalence of chronic diseases.
The dual-chamber segment will witness a significant growth rate during the forecast. It is attributable to it eliminates the need for transfer device and multiple needles.
Based on type, the global Prefilled Syringes market bifurcated into disposable and reusable. The Disposable segment held maximum market share in 2019 and estimated to dominate the market by 2027. It is primarily attributed to these devices reduce contamination risks and growing usages of disposable devices in hospitals and home care settings.
The reusable segment will be the fastest-growing segment as the surge in the development of advanced self-injectors.
On the basis of application, the global prefilled syringes market segregated into Anaphylaxis, Rheumatoid Arthritis, Diabetes, and Others (Vaccine, Biotech drug). Diabetes segment expected to gain maximum revenue by 2027 owing to the increasing prevalence of diabetes, which requires constant medications for treatment.
The Rheumatoid Arthritis will witness a higher growth rate during the forecast timeline on account of rheumatoid arthritis causes severe pain, redness, heat, and swelling and treatment of such diseases, which involves steroidal drugs.
Based on the distribution channel, the global prefilled syringes market categorized into Hospitals, Mail Order Pharmacies, and Ambulatory Surgery Centers. The hospital segment accounted for a higher revenue share in 2019, and it is anticipated to witness robust growth over the forecast period. It is due to the availability of prefilled syringes to help in an emergency and avoid errors during emergency treatments and surgery rooms to save time.
The Mail Order Pharmacies segment will grow in the forecast period attributable to it help serve patients suffering from chronic conditions such as anaphylaxis and diabetes.
Based on geography, the global Prefilled Syringes market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. Europe estimated to occupy the lion’s market share by 2027, owing to the growing prevalence of chronic diseases, the aging population susceptible to chronic disease growth in the biologics and biosimilars market coupled with a strong presence of major market players in these regions.
The Asia Pacific will be the fastest-growing segment during the forecast timeline due to the increasing aging population, increment in the prevalence of diabetes, and huge patient population.
Companies such as Becton, Dickinson and Company, Gerresheimer AG, West Pharmaceutical Services, Inc., SCHOTT AG, Ompi, Vetter Pharma International GmbH, Catalent, Inc., Weigao Group, Nipro Corporation, MedPro Inc., Fresenius Kabi, Stevanato Group, Novartis, Mylan, and Weigao are the key players in the Global Prefilled Syringes Market.
By Distribution Channel